Trial Profile
An Exploratory, Randomized, Single Blinded, Placebo-Controlled, Dose-Ranging Study of the Safety and Efficacy of "MILNACIPRAN" in Subjects With Chronic Shoulder Pain
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Milnacipran (Primary)
- Indications Shoulder pain
- Focus Therapeutic Use
- 08 Aug 2012 Actual end date (June 2011) added as reported by ClinicalTrials.gov.
- 14 Feb 2011 New trial record